BioSpace News Archive

Job Trends

Pfizer Transfers 100 Jobs to La Jolla Oncology Site as It Closes Facility in South San Francisco

Pfizer’s La Jolla cancer research center is set to grow by about 100 people. The pharma giant is transferring employees from a recently shuttered South San Francisco immunology site to bolster the work conducted near San Diego.

December 12, 2018
·
2 min read
·
Alex Keown
Medical Experts Suggest an Alarming Rise in Lung Cancer in Non-Smokers in the UAE

There are an estimated 150 cases of lung cancer per year in the UAE,around 40 – 50 percent of these cases are at an advanced mostly incurable stage

December 12, 2018
·
3 min read
Business

Former Eli Lilly Executive to Head New Immunology Division of the Allen Institute

Microsoft co-founder Paul Allen set aside $125 million to fund a new division at a scientific institute he founded to focus on understanding the immune system. This morning, it was reported that the Allen Institute is expanding.

December 12, 2018
·
2 min read
·
Alex Keown
Policy

Lawsuit Charges FDA, NIH With Failing to Follow Established Law for Reporting of Clinical Trial Data

The lawsuit alleges that the government is letting a number of researchers off the hook of reporting clinical data.

December 12, 2018
·
2 min read
·
Alex Keown
Drug Development

OncoSec Reports Updated Tumor Responses in KEYNOTE-695 Study of TAVO™ + KEYTRUDA® in Refractory Metastatic Melanoma

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced an update regarding tumor responses in its KEYNOTE-695 global, multicenter Phase 2b, open-label trial of intratumoral delivery of TAVO

December 12, 2018
·
6 min read
Genetown

Fresenius Medical Care North America Contributes Record Funding to National Kidney Foundation

Fresenius Medical Care North America (FMCNA), the world’s largest provider of dialysis products and services, raised more than $800,000 for the National Kidney Foundation (NKF) centerpiece Kidney Walk fundraiser, the nation’s largest fundraising initiative to fight kidney disease.

December 12, 2018
·
3 min read
BioCapital

SOC Telemed Creates teleNeurology Council

Brain Trust To Oversee Company’s Neurology Excellence Practices, Patient Outcomes and Quality

December 12, 2018
·
7 min read
BioCapital

Authorized Generic for EVZIO® (naloxone HCl injection) to be Available at a Reduced List Price of $178

Kaléo, a privately-held pharmaceutical company, today announced that it will offer an authorized generic of its EVZIO® (naloxone HCl injection) take home naloxone product at a list price of $178 per carton (each carton contains two auto-injectors).

December 12, 2018
·
6 min read
Pharm Country

HealthVerity Joins Exclusive Group of Leaders as New Member of Hyperledger

Announced today at the Global Forum in Basel, Switzerland, HealthVerity has joined Hyperledger, an open source effort created to advance cross-industry blockchain technologies.

December 12, 2018
·
2 min read
Pharm Country

Relmada Therapeutics Presents Clinical Data on Increased BDNF Plasma Levels in Subjects Treated with REL-1017

Relmada Therapeutics, Inc. (OTCQB: RLMD), announced today that clinical data demonstrating increased plasma levels of brain derived neurotrophic factor (BDNF) in healthy subjects treated with REL-1017 (dextromethadone) were presented at the annual American College of Neuropsychopharmacology meeting

December 12, 2018
·
5 min read